心力衰竭护士专科会诊:对心力衰竭和射血分数降低患者的药物滴定和心血管事件的影响。

IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Jose Lopez-Aguilera, Jorge Perea-Armijo, Ana Belen Muñoz-Villarreal, Antonia Cepas-Sosa, Luisa Maria Luque-Serrano, Nerea Aguayo-Caño, Gloria Maria Heredia-Campos, Juan Diego Martin-Diaz, Rafael Gonzalez-Manzanares, Juan Carlos Castillo-Dominguez, Manuel Crespin-Crespin, Monica Delgado-Ortega, Martin Ruiz-Ortiz, Dolores Mesa-Rubio, Manuel Pan-Alvarez Osorio, Manuel Anguita-Sanchez
{"title":"心力衰竭护士专科会诊:对心力衰竭和射血分数降低患者的药物滴定和心血管事件的影响。","authors":"Jose Lopez-Aguilera, Jorge Perea-Armijo, Ana Belen Muñoz-Villarreal, Antonia Cepas-Sosa, Luisa Maria Luque-Serrano, Nerea Aguayo-Caño, Gloria Maria Heredia-Campos, Juan Diego Martin-Diaz, Rafael Gonzalez-Manzanares, Juan Carlos Castillo-Dominguez, Manuel Crespin-Crespin, Monica Delgado-Ortega, Martin Ruiz-Ortiz, Dolores Mesa-Rubio, Manuel Pan-Alvarez Osorio, Manuel Anguita-Sanchez","doi":"10.3390/jcm14186681","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> The increasingly active role of nurses in the management of heart failure (HF) has become important in HF units (HCUs). This study aims to determine the effect of opening a specialised HF nursing (NSHF) consultation in a tertiary hospital on drug titration, and its subsequent impact on cardiac remodelling and prognosis. <b>Methods:</b> A retrospective cohort study was conducted on patients with HF with reduced ejection fraction (HFrEF) who were treated between 2017 and 2020. Patients who were followed by the NSHF were compared with those who underwent conventional clinical follow-up (non-NSHF), focusing on drug optimisation, echocardiographic parameters, biomarkers, and clinical outcomes in terms of mortality and hospital readmissions for HF. <b>Results:</b> A total of 411 patients were analysed, 85 of whom (20.7%) were treated with NSHF. There were hardly any differences in baseline characteristics. At the end of follow-up, the NSHF group had a higher prescription rate of angiotensin receptor-neprilysin inhibitor (+31.7% vs. +23.3%; <i>p</i> < 0.001), beta-blockers (+2.4% vs. -5.8%; <i>p</i> < 0.001), and sodium glucose co-transporter type 2 inhibitors (+24.7% vs. +17.8%; <i>p</i> < 0.001). There was also a higher rate of loop diuretic withdrawal (-16.7% vs. -6.7%; <i>p</i> < 0.001). However, no improvement in reverse remodelling or neurohormonal response was observed. Patients treated with NSHF had a lower probability of dying from HF (88.6% vs. 63.3%; <i>p</i> = 0.006), but this did not reduce hospital admissions for HF. <b>Conclusions:</b> Patients with HFrEF who are cared for through NSHF are more likely to be prescribed drugs that modify the prognosis of the disease. This has an impact on their mortality.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 18","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12470533/pdf/","citationCount":"0","resultStr":"{\"title\":\"Nurse Specialising Consultation in Heart Failure: Impact on Drug Titration and Cardiovascular Events in Patients with Heart Failure and Reduced Ejection Fraction.\",\"authors\":\"Jose Lopez-Aguilera, Jorge Perea-Armijo, Ana Belen Muñoz-Villarreal, Antonia Cepas-Sosa, Luisa Maria Luque-Serrano, Nerea Aguayo-Caño, Gloria Maria Heredia-Campos, Juan Diego Martin-Diaz, Rafael Gonzalez-Manzanares, Juan Carlos Castillo-Dominguez, Manuel Crespin-Crespin, Monica Delgado-Ortega, Martin Ruiz-Ortiz, Dolores Mesa-Rubio, Manuel Pan-Alvarez Osorio, Manuel Anguita-Sanchez\",\"doi\":\"10.3390/jcm14186681\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Introduction:</b> The increasingly active role of nurses in the management of heart failure (HF) has become important in HF units (HCUs). This study aims to determine the effect of opening a specialised HF nursing (NSHF) consultation in a tertiary hospital on drug titration, and its subsequent impact on cardiac remodelling and prognosis. <b>Methods:</b> A retrospective cohort study was conducted on patients with HF with reduced ejection fraction (HFrEF) who were treated between 2017 and 2020. Patients who were followed by the NSHF were compared with those who underwent conventional clinical follow-up (non-NSHF), focusing on drug optimisation, echocardiographic parameters, biomarkers, and clinical outcomes in terms of mortality and hospital readmissions for HF. <b>Results:</b> A total of 411 patients were analysed, 85 of whom (20.7%) were treated with NSHF. There were hardly any differences in baseline characteristics. At the end of follow-up, the NSHF group had a higher prescription rate of angiotensin receptor-neprilysin inhibitor (+31.7% vs. +23.3%; <i>p</i> < 0.001), beta-blockers (+2.4% vs. -5.8%; <i>p</i> < 0.001), and sodium glucose co-transporter type 2 inhibitors (+24.7% vs. +17.8%; <i>p</i> < 0.001). There was also a higher rate of loop diuretic withdrawal (-16.7% vs. -6.7%; <i>p</i> < 0.001). However, no improvement in reverse remodelling or neurohormonal response was observed. Patients treated with NSHF had a lower probability of dying from HF (88.6% vs. 63.3%; <i>p</i> = 0.006), but this did not reduce hospital admissions for HF. <b>Conclusions:</b> Patients with HFrEF who are cared for through NSHF are more likely to be prescribed drugs that modify the prognosis of the disease. This has an impact on their mortality.</p>\",\"PeriodicalId\":15533,\"journal\":{\"name\":\"Journal of Clinical Medicine\",\"volume\":\"14 18\",\"pages\":\"\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12470533/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/jcm14186681\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jcm14186681","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

导论:护士在心衰(HF)管理中日益积极的作用已成为心衰病房(hcu)的重要组成部分。本研究旨在确定在三级医院开设心衰专科护理(NSHF)会诊对药物滴定的影响,以及其对心脏重构和预后的影响。方法:回顾性队列研究2017 - 2020年间接受治疗的HF伴射血分数降低(HFrEF)患者。将接受NSHF随访的患者与接受常规临床随访(非NSHF)的患者进行比较,重点关注药物优化、超声心动图参数、生物标志物以及心衰死亡率和再入院率方面的临床结果。结果:共分析411例患者,其中85例(20.7%)接受了NSHF治疗。在基线特征上几乎没有任何差异。随访结束时,NSHF组的血管紧张素受体-奈普利素抑制剂(+31.7% vs +23.3%, p < 0.001)、β受体阻滞剂(+2.4% vs -5.8%, p < 0.001)和葡萄糖共转运蛋白2型钠抑制剂(+24.7% vs +17.8%, p < 0.001)的处方率较高。利尿剂循环停药率也较高(-16.7% vs -6.7%; p < 0.001)。然而,没有观察到反向重塑或神经激素反应的改善。接受NSHF治疗的患者死于HF的概率较低(88.6% vs. 63.3%; p = 0.006),但这并没有减少HF住院率。结论:通过NSHF治疗的HFrEF患者更有可能得到改善疾病预后的处方药。这对它们的死亡率有影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Nurse Specialising Consultation in Heart Failure: Impact on Drug Titration and Cardiovascular Events in Patients with Heart Failure and Reduced Ejection Fraction.

Nurse Specialising Consultation in Heart Failure: Impact on Drug Titration and Cardiovascular Events in Patients with Heart Failure and Reduced Ejection Fraction.

Nurse Specialising Consultation in Heart Failure: Impact on Drug Titration and Cardiovascular Events in Patients with Heart Failure and Reduced Ejection Fraction.

Nurse Specialising Consultation in Heart Failure: Impact on Drug Titration and Cardiovascular Events in Patients with Heart Failure and Reduced Ejection Fraction.

Introduction: The increasingly active role of nurses in the management of heart failure (HF) has become important in HF units (HCUs). This study aims to determine the effect of opening a specialised HF nursing (NSHF) consultation in a tertiary hospital on drug titration, and its subsequent impact on cardiac remodelling and prognosis. Methods: A retrospective cohort study was conducted on patients with HF with reduced ejection fraction (HFrEF) who were treated between 2017 and 2020. Patients who were followed by the NSHF were compared with those who underwent conventional clinical follow-up (non-NSHF), focusing on drug optimisation, echocardiographic parameters, biomarkers, and clinical outcomes in terms of mortality and hospital readmissions for HF. Results: A total of 411 patients were analysed, 85 of whom (20.7%) were treated with NSHF. There were hardly any differences in baseline characteristics. At the end of follow-up, the NSHF group had a higher prescription rate of angiotensin receptor-neprilysin inhibitor (+31.7% vs. +23.3%; p < 0.001), beta-blockers (+2.4% vs. -5.8%; p < 0.001), and sodium glucose co-transporter type 2 inhibitors (+24.7% vs. +17.8%; p < 0.001). There was also a higher rate of loop diuretic withdrawal (-16.7% vs. -6.7%; p < 0.001). However, no improvement in reverse remodelling or neurohormonal response was observed. Patients treated with NSHF had a lower probability of dying from HF (88.6% vs. 63.3%; p = 0.006), but this did not reduce hospital admissions for HF. Conclusions: Patients with HFrEF who are cared for through NSHF are more likely to be prescribed drugs that modify the prognosis of the disease. This has an impact on their mortality.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Clinical Medicine
Journal of Clinical Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
5.70
自引率
7.70%
发文量
6468
审稿时长
16.32 days
期刊介绍: Journal of Clinical Medicine (ISSN 2077-0383), is an international scientific open access journal, providing a platform for advances in health care/clinical practices, the study of direct observation of patients and general medical research. This multi-disciplinary journal is aimed at a wide audience of medical researchers and healthcare professionals. Unique features of this journal: manuscripts regarding original research and ideas will be particularly welcomed.JCM also accepts reviews, communications, and short notes. There is no limit to publication length: our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信